A recent study, led by Mohamed Abdel-Fattah, MD, evaluated the clinical and cost-effectiveness of invasive urodynamic investigations in managing refractory overactive bladder or urgency-predominant mixed urinary incontinence in women. Results published in The Lancet and presented at the European Association of Urology Congress 2025 showed that invasive urodynamic testing did not significantly improve treatment outcomes and was not cost-effective compared with clinical assessment alone. The study, conducted across 63 hospitals in the U.K., concluded that routine use of urodynamics in this patient population is not supported.

Source: The Lancet